For: | Zhang CC, Chen P. Anti-programmed death 1 antibody in the treatment of coexistent Mycobacterium fortuitum and lung cancer: A case report. World J Clin Cases 2022; 10(12): 3801-3807 [PMID: 35647142 DOI: 10.12998/wjcc.v10.i12.3801] |
---|---|
URL: | https://www.wjgnet.com/2307-8960/full/v10/i12/3801.htm |
Number | Citing Articles |
1 |
Yanqing He, Duanyang Peng, Pingan Liang, Jie Long, Anwen Liu, Zhimin Zeng. Immune Checkpoint Inhibitors and Tuberculosis Infection in Lung Cancer: A Case Series and Systematic Review With Pooled Analysis. The Journal of Clinical Pharmacology 2023; 63(4): 397 doi: 10.1002/jcph.2170
|
2 |
Fumihiro Kashizaki, Kentaro Yumoto, Nanami Tsuchiya, Shohei Watanabe, Shiori Shonai, Ryusuke Orii, Reeko Osada, Mai Kaneko, Akitomo Kikuchi, Yui Kojima, Hiroyuki Osawa, Harumi Koizumi, Kenichi Takahashi. Clinical Features of Simultaneous Diagnoses of Lung Cancer and Non-Tuberculous Mycobacterial Lung Disease: A Systematic Review and Pooled Analysis. Journal of Clinical Question 2025; 2(1): e2 doi: 10.69854/jcq.2025.0005
|
3 |
Alissa I Elanjian, Jason P Law, Borys Hrinczenko. Mycobacterium gordonae Infection in a Patient With Non-small Cell Lung Cancer. Cureus 2024; doi: 10.7759/cureus.54689
|